Long Zhi Investment Management

Long Zhi was founded by Chen Zhi, who serves as Chairman and directs the firm's investment strategy. Chen Zhi personally leads the investment committee, which reviews all potential deals and monitors portfolio companies. The firm's lean structure means that all acquisition decisions ultimately trace back to the founder's approval, consistent with the centralized governance model common among Chinese mid-market private equity managers.

Long Zhi concentrates on two principal sectors: healthcare and consumer goods. Within healthcare, the firm focuses on pharmaceutical distribution, medical-device manufacturing, and health-services companies that stand to benefit from China's regulatory consolidation. Within consumer goods, Long Zhi prioritizes branded products tied to rising domestic household spending, particularly in food and beverage categories where distribution networks create defensible competitive positions.

Long Zhi invests directly into portfolio companies rather than allocating capital to third-party fund managers. The firm originates, underwrites, and manages each investment internally. It does not participate as a limited partner in other private equity funds. Co-investment alongside external GPs is not a publicly documented feature of Long Zhi's deployment model.

Long Zhi relies on the founder's network within China's pharmaceutical and medical-device industries, combined with referrals from domestic banks and local government investment-promotion bodies. Because many of its target companies operate in licensing-intensive sub-sectors, proprietary sourcing often emerges from regulatory advisory relationships that predate formal auction processes. The firm does not publicize any systematic outbound origination program.

Long Zhi has not published an aggregate AUM figure through any Shenzhen or Shanghai private-equity association filing or onshore fund-disclosure platform. The firm raises capital on a deal-by-deal or close-ended RMB fund basis from Chinese institutional investors, and its total committed capital under management remains unverifiable from public sources. The AUM band is listed as Undisclosed.